The Dime cover art

The Dime

The Dime

By: Bryan Fields & Kellan Finney
Listen for free

LIMITED TIME OFFER | £0.99/mo for the first 3 months

Premium Plus auto-renews at £8.99/mo after 3 months. Terms apply.

About this listen

 The $100+ billion cannabis industry is fueled by innovative strategies and visionary leaders. Each week, we explore the journeys of CEOs from publicly traded giants, world-renowned scientists, and underground legacy growers shaping the future of this transformative market. Bryan and Kellan uncover how these pioneers built their businesses, navigated failures and found success in this rapidly growing space. Join us to explore the lessons and insights driving the cannabis industry forward.© 2026 The Dime Economics Leadership Management Management & Leadership Science
Episodes
  • Robotics vs Automation in Cannabis Manufacturing ft. Nohtal Partansky

    Robotics vs Automation in Cannabis Manufacturing ft. Nohtal Partansky
    Jan 22 2026

    Most cannabis automation fails for a simple reason.
    It optimizes motion instead of understanding.

    Automation executes. Robotics adapts.
    That distinction matters in an industry where variability is unavoidable and capital is limited.

    This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.

    This week, we sit down with Nohtal Partansky to cover:

    • Why automation breaks under variability
    • Automation vs robotics, clearly defined
    • How to avoid expensive missteps

    Chapters

    00:00 Understanding Automation in Cannabis Manufacturing

    03:02 The Role of Robotics vs. Automation

    05:45 Consultative Approach to Automation

    08:54 Challenges in Cultivation Automation

    11:59 Designing for Variability in Automation

    15:01 Iterative Development and Customer Feedback

    18:08 Identifying Design vs. Customer Issues

    21:06 Adapting to Environmental Nuances

    23:55 Conveying Value in Automation Solutions

    27:09 Strategic Approaches to Automation in Supply Chain

    30:10 Optimizing Pre-Roll Production Processes

    33:44 Understanding Tolerance Levels in Manufacturing

    36:39 Intellectual Property in the Cannabis Industry

    42:26 Innovations in Cannabis Manufacturing

    45:32 Challenges in Automation and Scaling

    50:51 Improving Processes and Training in Cannabis Operations

    Summary

    In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.

    Guest Links

    • https://www.instagram.com/sortingroboticsinc/
    • https://www.youtube.com/@sortingrobotics
    • https://www.linkedin.com/company/sortingrobotics/
    • https://www.sortingrobotics.com/
    • https://www.linkedin.com/in/nohtal/

    Our Links

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    Show More Show Less
    51 mins
  • Building Jaunty Into One of New York’s Top Cannabis Brands ft. Nicolas Guarino

    Building Jaunty Into One of New York’s Top Cannabis Brands ft. Nicolas Guarino
    Jan 15 2026
    Jaunty’s rise to the top of the New York cannabis market was not an overnight success.It was built through discipline in a market uniquely designedNew York’s rollout remains unforgiving.One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.This week we sit down with Nick to discuss:Why consistency becomes the only real moat as prices fallHow New York’s rollout punished assumptions and rewarded preparednessCapital discipline, supplier trust, and avoiding overspend death spiralsChapters00:00 Introduction to Jaunty and Nicolas Guarino03:06 The Journey into the Cannabis Industry06:07 Challenges and Lessons Learned in CBD09:00 Transitioning to Recreational Cannabis11:54 Building a Brand in a Competitive Market15:07 Navigating Market Dynamics and Growth Challenges18:07 The Importance of Support and Resilience20:49 Understanding Market Economics and Consumer Behavior23:55 Future Prospects for Cannabis in New York31:48 The Economics of Cannabis Production36:29 The Importance of Consistency in Branding41:11 Navigating Challenges in Cannabis Operations46:10 Strategic Planning for Future Growth51:56 Inventory Management and Cost Control56:02 Preparing for Market Consolidation58:11 Final Thoughts and Future Directions About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.SummaryIn this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.Guest Linkshttps://jaunty.com/https://x.com/getjauntyhttps://www.linkedin.com/company/get-jauntyhttps://www.instagram.com/get_jaunty/https://www.linkedin.com/in/nicolas-guarino-43939b103/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube: The Dime📸 Instagram: The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    Show More Show Less
    57 mins
  • How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick

    How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick
    Jan 8 2026

    Before CBD was discussed by a President in the Oval Office, it was a medical necessity.

    The Charlotte Figi story is well documented — and powerful.
    Not because it was emotional, but because it forced a serious medical conversation.

    Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.

    Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.

    This week, we sit down with Bill Morachnick to break down:

    • Why CBD earned acceptance through medical trust, not consumer marketing
    • How physician comfort, reimbursement pathways, and standards changed the conversation
    • CBD in the Oval Office — and what that signals for the future of cannabis

    Chapters

    00:00 Introduction to Charlotte's Web and Bill Morachnick

    03:00 The Inspiring Story of Charlotte Figi

    05:51 The Executive Order and Its Implications

    08:59 The Role of Education in CBD Acceptance

    12:12 Challenges and Misconceptions in the Cannabis Industry

    15:03 The Future of CBD and Medical Recommendations

    18:06 The Impact of Federal Reimbursement on CBD

    21:08 Defloria and the Future of Cannabis Research

    24:01 Navigating Regulatory Changes and Industry Challenges

    27:03 The Importance of Quality and Consistency in CBD Products

    30:02 The Potential for Pharmaceutical Collaborations

    33:04 Looking Ahead: The Future of CBD and Cannabis

    36:13 Final Thoughts and Audience Engagement

    Summary

    In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.

    Guest Links:

    • https://www.trycharlottesweb.com/
    • https://www.charlottesweb.com/
    • https://www.youtube.com/charlotteswebcbd
    • https://www.instagram.com/charlotteswebcbd/
    • https://www.linkedin.com/in/bill-morachnick-01318a6/
    • https://www.linkedin.com/company/charlottesweb/

    Our Links:

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    Show More Show Less
    50 mins
No reviews yet